Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody (Q46352552)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 20, 1992

edit

Language	Label	Description	Also known as
English	Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody	scientific article published on February 20, 1992

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

title

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody (English)

reason for preferred rank

most precise value

1 reference

stated in

Crossref

DOI

10.1038/355728A0

reference URL

https://api.crossref.org/works/10.1038/355728A0

retrieved

13 November 2022

Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1741059

retrieved

13 November 2022

main subject

prevention of HIV/AIDS

0 references

antibody

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

prevention

1 reference

based on heuristic

inferred from title

author name string

Emini EA

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

Schleif WA

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

Nunberg JH

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

Conley AJ

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

Eda Y

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

Tokiyoshi S

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

Putney SD

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

Matsushita S

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

Cobb KE

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

Jett CM

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

language of work or name

English

0 references

publication date

1 February 1992

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

20 February 1992

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

1741059

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1741059

retrieved

13 November 2022

number of pages

3

1 reference

based on heuristic

inferred from page(s)

full work available at URL

http://www.nature.com/articles/355728a0

1 reference

stated in

Crossref

DOI

10.1038/355728A0

reference URL

https://api.crossref.org/works/10.1038/355728A0

retrieved

13 November 2022

http://www.nature.com/articles/355728a0.pdf

file format

Portable Document Format

1 reference

stated in

Crossref

DOI

10.1038/355728A0

reference URL

https://api.crossref.org/works/10.1038/355728A0

retrieved

13 November 2022

published in

Nature

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

volume

355

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

issue

6362

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

page(s)

728-730

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

cites work

Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F355728A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F355728A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F355728A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies from human immunodeficiency virus-infected individuals bind to a short amino acid sequence that elicits neutralizing antibodies in animals

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F355728A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F355728A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F355728A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F355728A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F355728A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F355728A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F355728A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A microtiter cell-culture assay for the determination of anti-human immunodeficiency virus neutralizing antibody activity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F355728A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F355728A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1038/355728A0

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

Dimensions Publication ID

1040588876

0 references

PubMed publication ID

1741059

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1741059

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/1741059

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46352552&oldid=2207814234"